Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,665Revenue $M3,050Net Margin (%)25.5Z-Score4.2
Enterprise Value $M13,097EPS $8.4Operating Margin %51.4F-Score8
P/E(ttm))16.3Cash Flow Per Share $8.0Pre-tax Margin (%)42.3Higher ROA y-yY
Price/Book6.910-y EBITDA Growth Rate %14.0Quick Ratio2.6Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %19.6Current Ratio3.2Lower Leverage y-yY
Price/Cash Flow12.2y-y EBITDA Growth Rate %250ROA % (ttm)17.0Higher Current Ratio y-yN
Dividend Yield %0.5Insider Buy (3m)1ROE % (ttm)45.2Less Shares Outstanding y-yY
Payout Ratio %8.0Shares Outstanding M74.9ROI % (ttm)5.1Gross Margin Increase y-yY

Gurus Latest Trades with BCR

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRJoel Greenblatt 2014-09-30 Add0.27%$142.3 - $153.13
($147.81)
$ 169.114%Add 470.83%229,325
BCRJohn Hussman 2014-09-30 Buy 0.18%$142.3 - $153.13
($147.81)
$ 169.114%New holding, 15000 sh.15,000
BCRRay Dalio 2014-09-30 Add0.04%$142.3 - $153.13
($147.81)
$ 169.114%Add 115.75%59,086
BCRYacktman Focused Fund 2014-09-30 Reduce-0.22%$142.3 - $153.13
($147.81)
$ 169.114%Reduce -6.52%2,150,000
BCRDonald Yacktman 2014-09-30 Reduce-0.15%$142.3 - $153.13
($147.81)
$ 169.114%Reduce -3.85%6,443,334
BCRRobert Olstein 2014-06-30 Add0.15%$136.23 - $149.25
($142.86)
$ 169.118%Add 26.67%38,000
BCRJoel Greenblatt 2014-06-30 Add0.05%$136.23 - $149.25
($142.86)
$ 169.118%Add 187.29%40,174
BCRVanguard Health Care Fund 2014-06-30 Reduce-0.28%$136.23 - $149.25
($142.86)
$ 169.118%Reduce -37.07%1,157,400
BCRYacktman Fund 2014-06-30 Reduce-0.12%$136.23 - $149.25
($142.86)
$ 169.118%Reduce -2.76%3,330,000
BCRRay Dalio 2014-06-30 Reduce-0.02%$136.23 - $149.25
($142.86)
$ 169.118%Reduce -36.59%27,386
BCRVanguard Health Care Fund 2014-03-31 Add0.63%$125.42 - $146.57
($137.91)
$ 169.123%Add 505.6%1,839,200
BCRRay Dalio 2014-03-31 Add0.03%$125.42 - $146.57
($138.12)
$ 169.122%Add 118.27%43,186
BCRYacktman Focused Fund 2014-03-31 Reduce-0.91%$125.42 - $146.57
($137.91)
$ 169.123%Reduce -21.67%2,350,000
BCRDonald Yacktman 2014-03-31 Reduce-0.51%$125.42 - $146.57
($137.91)
$ 169.123%Reduce -11.96%6,827,627
BCRVanguard Health Care Fund 2013-12-31 Buy 0.13%$113.84 - $139.85
($132.09)
$ 169.128%New holding, 303700 sh.303,700
BCRYacktman Focused Fund 2013-12-31 Reduce-1.7%$113.84 - $139.85
($132.09)
$ 169.128%Reduce -29.91%3,000,000
BCRDonald Yacktman 2013-12-31 Reduce-1.09%$113.84 - $139.85
($132.09)
$ 169.128%Reduce -21.46%7,755,464
BCRYacktman Fund 2013-12-31 Reduce-0.45%$113.84 - $139.85
($132.09)
$ 169.128%Reduce -9.89%3,500,000
BCRRobert Olstein 2013-12-31 Reduce-0.11%$113.84 - $139.85
($132.09)
$ 169.128%Reduce -14.63%35,000
BCRRay Dalio 2013-12-31 Reduce-0.01%$113.84 - $139.85
($132.09)
$ 169.128%Reduce -30.54%19,786
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BCR John Hussman 2014-09-3015,0000.020.18New Buy
BCR Joel Greenblatt 2014-09-30229,3250.310.33+470.83%
BCR Ray Dalio 2014-09-3059,0860.080.07+115.75%
BCR Yacktman Fund 2014-09-303,250,0004.344-2.4%
BCR Donald Yacktman 2014-09-306,443,3348.63.8-3.85%
BCR Yacktman Focused Fund 2014-09-302,150,0002.873.3-6.52%
BCR Vanguard Health Care Fund 2014-09-301,039,1001.390.38-10.22%
BCR Robert Olstein 2014-09-3034,0000.050.63-10.53%
Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Luboff Sharon MGroup Vice President 2014-12-17Sell3,564$168.360.68view
Christian Patricia GVP -Quality, Reg & Med Affairs 2014-12-17Sell328$168.020.89view
Collins Timothy PGroup President 2014-12-17Sell3,960$168.410.65view
Beasley Jim CGroup President 2014-12-17Sell4,525$168.420.65view
DeFord John ASr. VP Sci Tech and Clin Afrs 2014-12-16Sell5,626$167.471.22view
Beasley Jim CGroup President 2014-12-16Sell14,634$167.471.22view
RING TIMOTHY MChairman and CEO 2014-12-16Sell15,232$166.61.75view
WEILAND JOHN HPresident and COO 2014-12-16Sell23,093$166.741.66view
Christian Patricia GVP -Quality, Reg & Med Affairs 2014-12-12Sell160$168.30.72view
Christian Patricia GVP -Quality, Reg & Med Affairs 2014-12-10Sell1,269$169.20.18view

Press Releases about BCR :

Quarterly/Annual Reports about BCR:

News about BCR:

Articles On GuruFocus.com
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 
Weekly 52-Week Highs Highlight: LBTYK, STZ, FISV, BCR Nov 09 2014 
Dividend Aristocrats In Focus Part 19 of 54: CR Bard Oct 15 2014 
Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
No More a Simple Distributor Sep 07 2014 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Yacktman Funds Comments on C.R. Bard Inc. Mar 12 2014 
Yacktman Fund Comments on C.R. Bard Inc. Jan 30 2014 


More From Other Websites
Bard Judge Says Implant Maker Facing Billions in Verdicts Dec 12 2014
Top Performing Funds: Core Style Straddles The Line Dec 10 2014
Bard Declares Quarterly Dividend Dec 10 2014
Bard Declares Quarterly Dividend Dec 10 2014
12 'financial potholes' to avoid now Dec 10 2014
The Cooper Companies Q4 Earnings, Revenues Lag; Up Y/Y Dec 05 2014
Top Performing Funds: Core Style Straddles The Line Dec 03 2014
Teleflex Partners with Premier to Expand Dialysis Portfolio Dec 03 2014
Henry Schein, Cardinal Health Sign Physician Service Deal Nov 25 2014
BARD C R INC /NJ/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation... Nov 21 2014
Invacare (IVC) Down to Strong Sell on Dismal Q3 Results Nov 20 2014
Henry Schein Strong on Healthy Track Record, Fundamentals Nov 20 2014
Bard to Present at the Piper Jaffray Healthcare Conference Nov 19 2014
CR Bard (BCR) Scales 52-Week High on Strong Q3 Results Nov 19 2014
LabCorp Shows Strength on Covance Buyout Plan, Robust Q3 Nov 17 2014
Cramer: Stocks That Stand Out Nov 17 2014
MWI Veterinary Beats Q4 Earnings & Sales yet Shares Fall Nov 12 2014
Henry Schein Tops Q3 Earnings, Revenues; Shares Rally Nov 11 2014
Steris Gains on Q2 Earnings and Revenue Beat; EPS View Up Nov 11 2014
CareFusion Q1 Earnings, Revenues Rise and Beat Estimates Nov 07 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK